Magnesium bioavailability from magnesium citrate and magnesium oxide.
- 1 February 1990
- journal article
- research article
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 9 (1) , 48-55
- https://doi.org/10.1080/07315724.1990.10720349
Abstract
This study compared magnesium oxide and magnesium citrate with respect to in vitro solubility and in vivo gastrointestinal absorbability. The solubility of 25 mmol magnesium citrate and magnesium oxide was examined in vitro in solutions containing varying amounts of hydrochloric acid (0-24.2 mEq) in 300 ml distilled water intended to mimic achlorhydric to peak acid secretory states. Magnesium oxide was virtually insoluble in water and only 43% soluble in simulated peak acid secretion (24.2 mEq hydrochloric acid/300 ml). Magnesium citrate had high solubility even in water (55%) and was substantially more soluble than magnesium oxide in all states of acid secretion. Reprecipitation of magnesium citrate and magnesium oxide did not occur when the filtrates from the solubility studies were titrated to pH 6 and 7 to stimulate pancreatic bicarbonate secretion. Approximately 65% of magnesium citrate was complexed as soluble magnesium citrate, whereas magnesium complexation was not present in the magnesium oxide system. Magnesium absorption from the two magnesium salts was measured in vivo in normal volunteers by assessing the rise in urinary magnesium following oral magnesium load. The increment in urinary magnesium following magnesium citrate load (25 mmol) was significantly higher than that obtained from magnesium oxide load (during 4 hours post-load, 0.22 vs 0.006 mg/mg creatinine, p less than 0.05; during second 2 hours post-load, 0.035 vs 0.008 mg/mg creatinine, p less than 0.05). Thus, magnesium citrate was more soluble and bioavailable than magnesium oxide.This publication has 14 references indexed in Scilit:
- Magnesium depletion, diuretics, and arrhythmiasThe American Journal of Medicine, 1987
- CALCIUM CITRATE: REDUCED PROPENSITY FOR THE CRYSTALLIZATION OF CALCIUM OXALATE IN URINE RESULTING FROM INDUCED HYPERCALCIURIA OF CALCIUM SUPPLEMENTATIONJournal of Clinical Endocrinology & Metabolism, 1985
- Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasisThe American Journal of Medicine, 1985
- CALCIUM BIOAVAILABILITY FROM CALCIUM CARBONATE ANDCALCIUM CITRATEJournal of Clinical Endocrinology & Metabolism, 1985
- Biochemical Effects in Patients with Calcium Oxalate Stone Disease during Combined Treatment with Bendroflumethiazide and Magnesium OxideBritish Journal of Urology, 1984
- Biochemical and Clinical Effects of the Prophylactic Treatment of Renal Calcium Stones with Magnesium HydroxideJournal of Urology, 1980
- Urine composition in patients with urolithiasis during treatment with magnesium oxideUrological Research, 1980
- Pathophysiological Studies in Idiopathic Hypercalciuria: Use of an Oral Calcium Tolerance Test to Characterize Distinctive Hypercalciuric Subgroups*Journal of Clinical Endocrinology & Metabolism, 1978
- A Simple Test for the Diagnosis of Absorptive, Resorptive and Renal HypercalciuriasNew England Journal of Medicine, 1975
- Control of crystallization in urineThe American Journal of Medicine, 1968